It has been hypothesized that detection and quantification of released fragments of aggrecan may be useful for monitoring cartilage turnover as well as predicting disease progression in osteoarthritis (OA) and RA [4,11,20,21]. This evidence concerns the gene ACAN and rheumatoid arthritis.